The Mirasol Evaluation Program:: Use of Mirasol Pathogen Reduction Technology for platelets in routine clinical practice

被引:0
|
作者
Cock, P. D. [1 ]
Vaquero, M.
Garcia, R.
Marceno, R.
Fusco, G. D.
Freitas, A. [1 ]
Goodrich, R.
机构
[1] Gambro BCT, Zaventem, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:156A / 156A
页数:1
相关论文
共 50 条
  • [1] Clinical Performance of Mirasol® Pathogen Reduction Technology Treated Platelets During Routine Use
    Antelo Caamano, M.
    Zalba Marcos, S.
    Ayape Puyales, L.
    Aranguren Azparren, A.
    Aranburu, E.
    Marschner, S.
    Cardoso, M.
    [J]. TRANSFUSION, 2011, 51 : 58A - 59A
  • [2] Evaluation of the quality of Apheresis platelets treated with Mirasol® pathogen reduction technology
    Eakins, E.
    Murphy, C.
    Croxon, H.
    Birhire, R.
    Flynn, N.
    Taylor, S.
    Murphy, W.
    [J]. TRANSFUSION, 2008, 48 (02) : 21A - 21A
  • [3] EVALUATION OF CYTOKINE ACCUMULATION IN MIRASOL® PATHOGEN REDUCTION TECHNOLOGY TREATED PLATELETS
    Castrillo, A.
    Abad, M. L.
    Arcas, C.
    Costoya, S.
    Rodriguez, M., I
    [J]. VOX SANGUINIS, 2010, 99 : 250 - 251
  • [4] COAGULATION POTENTIAL OF MIRASOL PATHOGEN REDUCTION TECHNOLOGY TREATED PLATELETS
    Marschner, S.
    Hovenga, N.
    Goodrich, R.
    [J]. VOX SANGUINIS, 2010, 99 : 247 - 248
  • [5] Inactivation of HCV with the Mirasol® Pathogen Reduction Technology
    Harb, M.
    Helle, F.
    Duverlie, G.
    [J]. TRANSFUSION, 2010, 50 : 211A - 211A
  • [6] Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis
    Janetzko, Karin
    Hinz, Katharina
    Marschner, Susanne
    Goodrich, Ray
    Klueter, Harald
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (05) : 309 - 315
  • [7] Prevention of alloimmunization to platelets and cardiac transplants by mirasol, pathogen reduction technology (PRT).
    Asano, Hiroshi
    Lee, Chih-Yuan
    Baldwin, William M.
    Marschner, Susanne
    Goodrich, Raymond
    [J]. BLOOD, 2006, 108 (11) : 282A - 282A
  • [8] EFFECT OF MIRASOL PATHOGEN REDUCTION TECHNOLOGY SYSTEM ON QUALITY OF PLATELETS STORED IN PLASMA
    Llohn, A.
    Skogheim, R.
    Flesland, A.
    Oedegaard, E.
    Mastroianni, M.
    Nybruket, M.
    Nentwich, I
    [J]. VOX SANGUINIS, 2011, 101 : 77 - 77
  • [9] Effect of mirasol pathogen reduction technology system on immunomodulatory molecules of apheresis platelets
    Valsami, S.
    Grouzi, E.
    Mochandreou, D.
    Pouliakis, A.
    Piroula-Godoy, M.
    Kokori, S.
    Pittaras, T.
    Raikou, A.
    Politou, M.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (01)
  • [10] Evaluation of navigant's MIRASOL pathogen reduction technology system for reduction of Babesia microti in apheresis platelets and plasma
    Tonnetti, L.
    Proctor, M. C.
    Reddy, H. L.
    Goodrich, R. P.
    Leiby, D. A.
    [J]. TRANSFUSION, 2007, 47 (03) : 131A - 131A